ipsen

Showing 4 posts of 34 posts found.

Exelixis signs $200 million licensing deal for cancer drug

March 1, 2016
Research and Development, Sales and Marketing Cancer, Cometriq, Exelixis, ipsen

Exelixis has signed a licensing agreement with French biotech firm Ipsen for its cancer drug Cometriq (cabozantinib) for an upfront …

Ipsen buys Syntaxin

July 16, 2013
Research and Development, Sales and Marketing R&D, ipsen, neurology, syntaxin, tsi

French pharma group Ipsen has snapped up privately-owned UK life sciences firm Syntaxin for an upfront payment of €28 million …

Photodynamic treatment for HPV shows potential

March 15, 2012
Research and Development Cancer, GE Healthcare, HPV, Photocure, ipsen, oncologly

A new photodynamic therapy treatment for human papilloma virus (HPV) associated diseases of the cervix has shown potential in a …

Claude Bertrand joins Ipsen as Chief Scientific Officer

October 27, 2009
Research and Development appointment, ipsen, research and development

Ipsen has appointed Claude Bertrand (pictured) chief scientific officer and Jacques-Pierre Moreau chief scientific advisor.Bertrand moves to the company next …

The Gateway to Local Adoption Series

Latest content